$ASEP began trading on the CSE Asep Medical Holdings just commenced trading on the CSE under the ticker $ASEP.CN.
$ASEP.CN combines two development-stage companies, Sepset Bioscience and ABT innovations. The company's purpose is to mitigate the global crisis of antibiotic failure. They offer this through diagnostic and therapeutic solutions.
$ASEP’s novel diagnostic assays proved early and rapid diagnosis of sepsis, offering dramatically faster diagnosis. Therapeutically, they have developed a patented peptide technology that targets infection, effectively treating antibiotic infections where nothing else works.
Their COO Dr. Robert Hancock is a veteran microbiologist with 40 years of experience in research and teaching. He’s published more than 760 papers and reviews and has more than 100,000 citations.
I’m really excited to see how this company performs in the coming weeks. The company IPO’d at $1.00, and currently, they are trading at $.850. $ASEP.CN is valued at $47.71 million.
https://ceo.ca/@newsfile/asep-medical-announces-listing-on-canadian-securities